It is obvious from the Patent application that something is being done to protect the use(s) of PBT2.
I have said over many years I like their medicine, but their business sense is rubbish. One day we may be told the basis of the UQ joint venture, and perhaps what was the selling point on the 5.3c, $35 million placement done at a premium.
The silence is deafening, but perhaps this time they are working to protect the compound and it's related molecular structures?
Just don't dilute us anymore until the share price is high enough
It is obvious from the Patent application that something is...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
0.001(12.5%) |
Mkt cap ! $23.94M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.5¢ | 0.4¢ | $508 | 124.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 103 | 97947018 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 31179262 | 15 |
View Market Depth
| Last trade - 11.42am 25/07/2024 (20 minute delay) ? |
| ATH (ASX) Chart |